Nrf2 activation enhances biliary excretion of sulfobromophthalein by inducing glutathione-S-Transferase activity

Toxicological Sciences

Volumn 109, Issue 1, 2009, Pages 24-30

  Reisman, Scott A ^a   Csanaky, Iván I ^a   Yeager, Ronnie I ^a   Klaassen, Curtis D ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Biliary excretion; BSP; Gsts; Nrf2

Indexed keywords

BROMSULFOPHTHALEIN; DIBROMOSULFOPHTHALEIN; GLUTATHIONE TRANSFERASE; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 2; TRANSCRIPTION FACTOR NRF2;

ANIMAL EXPERIMENT; ARTICLE; BILIARY EXCRETION; CHEMICAL ANALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENOTYPE; MALE; MOUSE; NONHUMAN; PLASMA CLEARANCE; PROTEIN FUNCTION; TRANSCRIPTION INITIATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANALYSIS OF VARIANCE; ANIMALS; BILIARY TRACT; CYTOSKELETAL PROTEINS; GENE KNOCKDOWN TECHNIQUES; GLUTATHIONE; GLUTATHIONE TRANSFERASE; INDICATORS AND REAGENTS; LIVER; MALE; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NF-E2-RELATED FACTOR 2; SULFOBROMOPHTHALEIN;

MUS;

EID: 65549142697     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfp045     Document Type: Article

References (36)

1. Aleksunes, L. M., and Manautou, J. E. (2007). Emerging role of Nrf2 in protecting against hepatic and gastrointestinal disease. Toxicol. Pathol. 35, 459-473.
2. Alin, P., Jensson, H., Guthenberg, C., Danielson, U. H., Tahir, M. K., and Mannervik, B. (1985). Purification of major basic glutathione transferase isoenzymes from rat liver by use of affinity chromatography and fast protein liquid chromatofocusing. Anal. Biochem. 146 313-320.
3. Aoki, Y., Sato, H., Nishimura, N., Takahashi, S., Itoh, K., and Yamamoto, M. (2001). Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust. Toxicol. Appl. Pharmacol. 173, 154-160.
4. Ballatori, N., and Truong, A. T. (1989). Relation between biliary glutathione excretion and bile acid-independent bile flow. Am. J. Physiol. 256, G22-G30.
5. Ballatori, N., and Truong, A. T. (1992). Glutathione as a primary osmotic driving force in hepatic bile formation. Am. J. Physiol. 263, G617-G624.
6. Bloom, D. A., and Jaiswal, A. K. (2003). Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/ accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:qUinone oxidoreductase-1 gene expression. J. Biol. Chem. 278, 44675-44682.
7. Brauer, R. W., and Pessotti, R. L. (1949). The removal of bromsulphthalein from blood plasma by the liver of the rat. J. Pharmacol. Exp. Ther. 97, 358-370.
8. Cattori, V., van Montfoort, J. E., Stieger, B., Landmann, L., Meijer, D. K., Winterhalter, K. H., Meier, P. J., and Hagenbuch, B. (2001). Localization of organic anion transporting polypeptide 4 (Oatp4) in rat liver and comparison of its substrate specificity with Oatp1, Oatp2 and Oatp3. Pflugers Arch. 443, 188-195.
9. Chan, K., Lu, R., Chang, J. C., and Kan, Y. W. (1996). NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. Proc. Natl. Acad. Sci. U.S.A. 93, 13943-13948.
10. Combes, B. (1965). The importance of conjugation with glutathione for sulfobromophthalein sodium (Bsp) transfer from blood to bile. J. Clin. Invest. 44, 1214-1224.
11. Combes, B., and Stakelum, G. S. (1960). Conjugation of sulfobromophthalein sodium with glutathione in thioether linkage by the rat. J. Clin. Invest. 39, 1214-1222.
12. Combes, B., and Stakelum, G. S. (1961). A liver enzyme that conjugates sulfobromophthalein sodium with glutathione. J. Clin. Invest. 40, 981-988.
13. Cui, Y., Konig, J., and Keppler, D. (2001). Vectorial transport by double-transfected cells expressing the human uptake transporter SLC21A8 and the apical export pump ABCC2. Mol. Pharmacol. 60, 934-943.
14. Enomoto, A., Itoh, K., Nagayoshi, E., Haruta, J., Kimura, T., O'Connor, T., Harada, T., and Yamamoto, M. (2001). High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol. Sci. 59, 169-177.
15. Goldstein, J., and Combes, B. (1966). Spectrophotometric assay of the liver enzyme that catalyzes sulfobromophthalein-glutathione conjugation. J. Lab. Clin. Med. 67, 863-872.
16. Gregus, Z., and Klaassen, C. D. (1982). Role of ligandin as a binding protein and as an enzyme in the biliary excretion of sulfobromophthalein. J. Pharmacol. Exp. Ther. 221, 242-246.
17. Grodsky, G. M., Carbone, J. V., and Fanska, R. (1959). Identification of metabolites of sulfobromophthalein. J. Clin. Invest. 38, 1981-1988.
18. Hagenbuch, B., Adler, I. D., and Schmid, T. E. (2000). Molecular cloning and functional characterization of the mouse organic-anion-transporting polypeptide 1 (Oatp1) and mapping of the gene to chromosome X. Biochem. J. 345(Pt 1), 115-120.
19. Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997). An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236, 313-322.
20. Javitt, N. B. (1964). Phenol 3, 6 dibromphthalein disulfonate, a new compound For the study of liver disease. Proc. Soc. Exp. Biol. Med. 117, 254-257.
21. Johnson, D. R., and Klaassen, C. D. (2002). Role of rat multidrug resistance protein 2 in plasma and biliary disposition of dibromosulfophthalein after microsomal enzyme induction. Toxicol. Appl. Pharmacol. 180, 56-63.
22. Kanai, N., Lu, R., Bao, Y., Wolkoff, A. W., and Schuster, V. L. (1996). Transient expression of oatp organic anion transporter in mammalian cells: Identification of candidate substrates. Am. J. Physiol. 270, F319-325.
23. Klaassen, C. D., and Plaa, G. L. (1967). Species variation in metabolism, storage, and excretion of sulfobromophthalein. Am. J. Physiol. 213, 1322-1326.
24. Kraft, A. D., Johnson, D. A., and Johnson, J. A. (2004). Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tertbutylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J. Neurosci. 24, 1101-1112.
25. Krebs, J. S., and Brauer, R. W. (1958). Metabolism of sulfobromophthalein sodium (BSP) in the rat. Am. J. Physiol. 194, 37-43.
26. Maher, J. M., Dieter, M. Z., Aleksunes, L. M., Slitt, A. L., Guo, G., Tanaka, Y., Scheffer, G. L., Chan, J. Y., Manautou, J. E., Chen, Y., et al. (2007). Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway. Hepatology 46, 1597-1610.
27. Okada, K., Shoda, J., Taguchi, K., Maher, J. M., Ishizaki, K., Inoue, Y., Ohtsuki, M., Goto, N., Takeda, K., Utsunomiya, H., et al. (2008). Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 295, G735-G747.
28. Ramos-Gomez, M., Kwak, M. K., Dolan, P. M., Itoh, K., Yamamoto, M., Talalay, P., and Kensler, T. W. (2001). Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 98, 3410-3415.
29. Reisman, S. A., Yeager, R. L., Yamamoto, M., and Klaassen, C. D. (2009). Increased Nrf2 Activation in livers from Keap1-knockdown mice increases expression of cytoprotective genes that detoxify electrophiles more than those that detoxify reactive oxygen species. Toxicol. Sci. 108 35-47.
30. Slitt, A. L., Cherrington, N. J., Maher, J. M., and Klaassen, C. D. (2003). Induction of multidrug resistance protein 3 in rat liver is associated with altered vectorial excretion of acetaminophen metabolites. Drug Metab. Dispos. 31, 1176-1186.
31. Solis, W. A., Dalton, T. P., Dieter, M. Z., Freshwater, S., Harrer, J. M., He, L., Shertzer, H. G., and Nebert, D. W. (2002). Glutamate-cysteine ligase modifier subunit: Mouse Gclm gene structure and regulation by agents that cause oxidative stress. Biochem. Pharmacol. 63, 1739-1754.
32. Tahir, M. K., Guthenberg, C., and Mannervik, B. (1985). Inhibitors for distinction of three types of human glutathione transferase. FEBS Lett. 181, 249-252.
33. Tanaka, H., Sano, N., and Takikawa, H. (2003). Biliary excretion of phenolphthalein sulfate in rats. Pharmacology 68, 177-182.
34. Tong, K. I., Kobayashi, A., Katsuoka, F., and Yamamoto, M. (2006). Two-site substrate recognition model for the Keap1-Nrf2 system: A hinge and latch mechanism. Biol. Chem. 387, 1311-1320.
35. van Montfoort, J. E., Schmid, T. E., Adler, I. D., Meier, P. J., and Hagenbuch, B. (2002). Functional characterization of the mouse organicanion-transporting polypeptide 2. Biochim. Biophys. Acta. 1564, 183-188.
36. Yalcin, S., Jensson, H., and Mannervik, B. (1983). A set of inhibitors for discrimination between the basic isozymes of glutathione transferase in rat liver. Biochem. Biophys. Res. Commun. 114, 829-834.